GlycoMimetics Inc (GLYC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

9708 MEDICAL CENTER DRIVE ROCKVILLE, MD 20850

GlycoMimetics, Inc. develops molecule drugs. The company offers research, development, and commercialization of specialized small molecule drug compounds for the treatment of blood cancers and certain inflammatory conditions.

Data as of 2021-05-08 11:25:26 -0400
Market Cap117.509 Million Shares Outstanding51.539 Million Avg 30-day Volume673.943 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-1.78 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.28353 52-week High/Low5.19 / 2.22 Next Earnings Date2021-07-30 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from GLYC instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 90 81 11.11% 32 (1.92%) 31 (1.93%) 3.23%
13F shares: 38.694 Million 39.693 Million -2.52% 20.105 Million 22.498 Million -10.63%
% Ownership 80.902 82.9892 -2.52% 42.0354 47.0377 -10.63%
New Positions: 21 8 162.5% 9 3 200.0%
Increased Positions 30 24 25.0% 14 9 55.56%
Closed Positions 12 13 -7.69% 8 7 14.29%
Reduced Positions 22 30 -26.67% 4 14 -71.43%
Total Calls 76.848 Thousand 940.354 Thousand -91.83% 35.4 Thousand 900 Thousand -96.07%
Total Puts 179.504 Thousand 84.812 Thousand 111.65% 37.7 Thousand 10.1 Thousand 273.27%
PUT/CALL Ratio 2.34 0.09 2500.0% 1.06 0.01 10500.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding GLYC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GLYC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FELDMAN ERIC JAY CHIEF MEDICAL OFFICER

  • Officer
50,498 2021-03-01 1

KING RACHEL K. PRESIDENT, CEO

  • Officer
  • Director
627,456 2021-01-20 2

HAHN BRIAN M. SVP FINANCE, CFO

  • Officer
39,760 2021-01-20 2

MAGNANI JOHN L. SVP OF RESEARCH, CSO

  • Officer
329,105 2021-01-20 1

THACKRAY HELEN M. SVP CLINICAL DEVELOPMENT, CMO

  • Officer
183,115 2021-01-20 1

GIRARD ARMAND SVP, CHIEF BUSINESS OFFICER

  • Officer
25,000 2021-01-20 1

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
9,323,615 2020-11-04 1

GOLDBERG MARK ALAN

  • Director
0 2020-05-22 1

PEARSON TIMOTHY R

  • Director
0 2020-05-22 1

JUNIUS DANIEL M

  • Director
0 2020-05-22 1

KOENIG SCOTT

  • Director
0 2020-05-22 1

ANDREWS PATRICIA S

  • Director
0 2020-05-22 1

JACKSON SCOTT THOMAS

  • Director
0 2020-05-22 1

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
528,891 2019-09-05 1

BARRETT M JAMES

  • Director
  • 10% Owner
0 2018-05-18 0

NEW ENTERPRISE ASSOCIATES 10 L P

NEA PARTNERS 10 L P

  • 10% Owner
4,995,664 2018-05-10 0

SANDELL SCOTT D

  • 10% Owner
9,089,041 2018-05-10 0

BARRIS PETER J

  • 10% Owner
9,089,041 2018-05-10 0

BALDWIN JOHN J.

  • Director
1,210 2016-06-29 0

TOP FRANKLIN H JR

  • Director
0 2016-05-17 0

HENOS MICHAEL A

  • Director
0 2015-07-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
GLYCOMIMETICS INC GLYC 2021-05-10 22:15:04 UTC -0.7381 0.7881 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 21:45:02 UTC -0.7381 0.7881 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 21:15:02 UTC -0.7381 0.7881 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 20:45:03 UTC -0.7381 0.7881 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 20:15:03 UTC -0.7381 0.7881 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 19:45:03 UTC -0.7381 0.7881 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 19:15:03 UTC -0.7381 0.7881 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 18:45:03 UTC -0.7381 0.7881 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 18:15:03 UTC -0.7381 0.7881 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 17:45:02 UTC -0.7381 0.7881 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 17:15:03 UTC -0.7381 0.7881 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 16:45:03 UTC -0.696 0.746 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 16:15:03 UTC -0.696 0.746 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 15:45:03 UTC -0.696 0.746 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 15:15:03 UTC -0.696 0.746 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 14:45:04 UTC -0.885 0.935 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 14:15:04 UTC -0.885 0.935 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 13:45:04 UTC -0.885 0.935 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 13:15:03 UTC -0.885 0.935 1100000
GLYCOMIMETICS INC GLYC 2021-05-10 12:45:02 UTC -0.885 0.935 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments